Southern Gastroenterology Associates, Llc | |
763 Old Norcross Rd Lawrenceville GA 30045-4317 | |
(678) 985-2000 | |
(678) 985-1999 |
Full Name | Southern Gastroenterology Associates, Llc |
---|---|
Speciality | Internal Medicine |
Location | 763 Old Norcross Rd, Lawrenceville, Georgia |
Authorized Official Name and Position | Mark B. Kukler (OWNER) |
Authorized Official Contact | 6789852000 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Southern Gastroenterology Associates, Llc 763 Old Norcross Rd Lawrenceville GA 30045-4317 Ph: (678) 985-2000 | Southern Gastroenterology Associates, Llc 763 Old Norcross Rd Lawrenceville GA 30045-4317 Ph: (678) 985-2000 |
NPI Number | 1205886504 |
---|---|
Provider Enumeration Date | 05/10/2006 |
Last Update Date | 05/30/2012 |
Medicare PECOS PAC ID | 8820084064 |
---|---|
Medicare Enrollment ID | O20040422000946 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1205886504 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
Provider Name | Tanya M Rutledge |
---|---|
Provider Type | Practitioner - Gastroenterology |
Provider Identifiers | NPI Number: 1952350332 PECOS PAC ID: 6103805288 Enrollment ID: I20040714000756 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Provider Name | Robert K Wade |
---|---|
Provider Type | Practitioner - Pathology |
Provider Identifiers | NPI Number: 1114911054 PECOS PAC ID: 0143288555 Enrollment ID: I20041230000432 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Provider Name | Althea H Mcphail |
---|---|
Provider Type | Practitioner - Pathology |
Provider Identifiers | NPI Number: 1508826215 PECOS PAC ID: 2163587635 Enrollment ID: I20090217000277 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Provider Name | Scott W Schorr |
---|---|
Provider Type | Practitioner - Gastroenterology |
Provider Identifiers | NPI Number: 1275583437 PECOS PAC ID: 1658443296 Enrollment ID: I20101020000721 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Provider Name | Arvind A Kulkarni |
---|---|
Provider Type | Practitioner - Gastroenterology |
Provider Identifiers | NPI Number: 1548210859 PECOS PAC ID: 7911079553 Enrollment ID: I20101020001007 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Provider Name | Mark B Kukler |
---|---|
Provider Type | Practitioner - Gastroenterology |
Provider Identifiers | NPI Number: 1093765265 PECOS PAC ID: 6002988649 Enrollment ID: I20101027000231 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Provider Name | Marcelle M Owens |
---|---|
Provider Type | Practitioner - Gastroenterology |
Provider Identifiers | NPI Number: 1295785814 PECOS PAC ID: 4284706821 Enrollment ID: I20101101000910 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Provider Name | Amil Patel |
---|---|
Provider Type | Practitioner - Gastroenterology |
Provider Identifiers | NPI Number: 1952588394 PECOS PAC ID: 5193987329 Enrollment ID: I20130325000351 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Provider Name | Stephen Beasley |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1568897668 PECOS PAC ID: 4789934589 Enrollment ID: I20201118002462 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Provider Name | Tariq I Salim |
---|---|
Provider Type | Practitioner - Gastroenterology |
Provider Identifiers | NPI Number: 1598293326 PECOS PAC ID: 2567731789 Enrollment ID: I20231122002621 |
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
News Archive
"There are three main options on the table" about what to do after the Millennium Development Goals expire in 2015, Leo Williams, chair of Beyond 2015, an international campaign that aims to "ensure that the process of developing a development framework is participatory, inclusive and responsive to those directly affected by poverty and injustice," writes in a post on the Guardian's "Poverty Matters Blog."
Spinal muscular atrophy, a neurodegenerative disorder that causes the weakening of muscles, is the leading cause of infant death and occurs in 1 in 6,000 live births.
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.
› Verified 4 days ago
Clinica Familiar Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 706 Grayson Hwy, Suite 216, Lawrenceville, GA 30045 Phone: 770-513-7711 Fax: 770-513-3352 | |
Raymond L. Stovall, M.d., P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 600 Professional Dr, Suite 150, Lawrenceville, GA 30045 Phone: 678-376-1800 Fax: 678-376-5500 | |
Physicians Pointe Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1925 Old Peachtree Rd Ne, Lawrenceville, GA 30043 Phone: 770-339-5999 Fax: 770-277-9159 | |
Carehere Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 750 S Perry St Ste 200, Lawrenceville, GA 30046 Phone: 877-423-1330 | |
Bennett H. Bruckner,m.d., P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 575 Professional Dr, Suite 290, Lawrenceville, GA 30045 Phone: 770-962-9410 Fax: 770-962-8489 | |
Metabolic Health Of Lawrenceville Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 720 Old Snellville Hwy Ste 150, Lawrenceville, GA 30044 Phone: 678-431-1119 | |
Sugarloaf Primary Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4835 Sugarloaf Pkwy, Suite 300, Lawrenceville, GA 30044 Phone: 407-375-5940 Fax: 407-375-5952 |